T. Tominaga

Competitive Strategies for Japanese Clinical Trial Sites

T. Tominaga, 2014, Therapeutic innovation & regulatory science.

The ICH, the GHTF, and the Future of Harmonization Initiatives

T. Tominaga, 2013, Therapeutic innovation & regulatory science.

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE DRAFT CONSENSUS GUIDELINE

S. Vamvakas, M. Kubota, S. Kopp, 2002 .

International models of investigator-initiated trials: implications for Japan.

E. Trimble, J. Ledermann, K. Kurokawa, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

The Japanese Postmarketing Adverse Event Relief System: A Confluence of Regulatory Science, the Legal System, and Clinical Pharmacology

T. Tominaga, Y. Oniyama, T. Kondo, 2017, Clinical pharmacology and therapeutics.

Regulatory Science as a Bridge Between Science and Society

Y. Uyama, Y. Asahina, T. Tominaga, 2011, Clinical pharmacology and therapeutics.

The Value and Benefits of the International Conference on Harmonisation to Drug Regulatory Authorities: Advancing Harmonization for Better Public Health

L Hunt, T. Tominaga, T Tominaga, 2011, Clinical pharmacology and therapeutics.

Rapid Globalization of Medical Device Clinical Development Programs in Japan　- The Case of Drug-Eluting Stents.

T. Tominaga, Yuka Suzuki, Madoka Murakami, 2017, Circulation journal : official journal of the Japanese Circulation Society.

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

W Goettsch, D Samaha, S. Schneeweiss, 2015, Clinical pharmacology and therapeutics.